格隆汇9月25日丨国投丰乐(000713.SZ)公布，近日收到控股股东国投种业科技有限公司（简称"国投种 业"）出具的《关于自愿延长股份锁定期的承诺函》，基于对公司未来发展的信心及价值判断，为促进 公司持续、稳定、健康发展，维护广大投资者利益，自愿承诺延长其持有的122,802,996股公司股份的锁 定期。国投种业承诺通过协议转让已取得的122,802,996股国投丰乐股份，锁定期到期日由2025年10月25 日延长至2028年10月25日。 ...

Group 1 - Company Hualian Holdings (000036.SZ) plans to invest RMB 50 million in Chengdu Ideal Realm Technology Co., Ltd. (referred to as "Ideal Realm") through a capital increase agreement, acquiring a 2.7778% stake in the company [1][2] - The investment will consist of RMB 4.4924 million for subscribing to the new registered capital, with the remaining RMB 49.955076 million allocated to capital reserves [1] - The related party, Shenzhen Hengyu Capital Management Co., Ltd. (referred to as "Hengyu Capital"), will also invest RMB 100 million in Ideal Realm, obtaining a 5.555556% stake after the capital increase [2] Group 2 - Hengyu Capital has the option to designate an associated third party to invest RMB 50 million under the same conditions as its own investment [2] - Ideal Realm's main business focuses on AR glasses and vehicle display technology, with its self-developed Fiber Scanning Display (FSD) technology being distinct from semiconductor processes [2] - The AR glasses produced by Ideal Realm are characterized by a small target area, low power consumption, and high PPI, catering to the consumer market [2]

Core Viewpoint - Mees Health (02415.HK) announced that its subsidiary, Shanghai Mees Pharmaceutical Technology Co., Ltd., has won a large real-world research project from a Chinese pharmaceutical company, focusing on the efficacy and safety of IL-1β monoclonal antibody treatment for gout patients [1] Group 1 - The project aims to systematically evaluate the effectiveness and safety of IL-1β monoclonal antibody treatment for patients during both acute and intercritical phases of gout through a combination of prospective and retrospective observational studies [1] - The project is valued at approximately RMB 21 million [1] - The group leverages over a decade of experience in its internet doctor platform, utilizing big data and artificial intelligence technologies to connect doctors, patients, and medical device companies, thereby providing digital solutions to enhance the healthcare ecosystem and improve medical quality [1]

Group 1 - The core point of the article is the appointment of Liu Hui as the Executive Director and General Manager of China Shipbuilding Leasing, effective from September 25, 2025 [1] - Liu Hui will also serve as a member of the Strategic and Investment Committee, as well as the ESG and Sustainable Development Committee [1]

格隆汇9月25日丨酷派集团(02369.HK)公告，9月25日耗资137.5万港元回购108.8万股。 ...

格隆汇9月25日丨北新路桥(002307.SZ)公布，近日收到新疆生产建设兵团第二师交通运输事业发展中心 （铁门关市交通运输事业发展中心）发来的中标通知书，根据《中标通知书》，本公司被确定为第二师 G687铁门关—阿拉尔公路（第五合同段）施工项目中标人。中标金额为人民币肆亿叁仟叁佰捌拾玖万 壹仟玖佰捌拾捌元玖角整（￥433,891,988.90）。 ...

Core Viewpoint - ZTE Corporation (000063.SZ) clarified on its interactive platform that while its products utilize printed circuit boards (PCBs), the company does not engage in the production, manufacturing, or sales of PCBs [1] Group 1 - ZTE Corporation's products incorporate PCB technology [1] - The company explicitly stated it does not participate in PCB production [1] - There is no involvement in the manufacturing or sales of PCBs by ZTE Corporation [1]

Core Viewpoint - Future World Holdings (00572.HK) announced the sale of 6.31 million shares of Shankou Holdings at a total consideration of approximately HKD 30.88 million, with the sale price ranging from HKD 4.80 to HKD 5.13 per share [1] Group 1 - The average sale price per share of Shankou Holdings, excluding transaction costs, was approximately HKD 4.89 [1] - The shares sold represent about 0.1% of the total issued shares of Shankou Holdings as of the announcement date [1] - After the sale, the company no longer holds any shares in Shankou Holdings [1] Group 2 - The transaction was conducted in the open market, making it impossible to determine the identity of the counterparties involved in the sale [1] - The company confirmed that the counterparties and their ultimate beneficial owners are independent third parties after reasonable inquiries by the directors [1]

格隆汇9月25日丨*ST奥维(002231.SZ)公布，公司于近日通过中国执行信息公开网公示信息查询到公司 控股股东、实际控制人的一致行动人上海东和欣新材料集团有限公司（简称"上海东和欣"）被上海市松 江区人民法院列为失信被执行人。公司已第一时间向上海东和欣进行核实，截至本公告披露日，尚未收 到上海东和欣回复。截至2025年6月30日，上海东和欣及其关联方仍有18,607.30万元资金占用款尚未偿 还，公司控股股东、实际控制人的一致行动人上海东和欣被列为失信被执行人将导致公司收回资金占用 款存在较大的不确定性。 ...

根据协议安排，公司控股子公司南宁东方雨虹新材料有限公司（简称"南宁东方雨虹"、"项目公司"）作 为项目实施主体，以自筹资金投资不超过6亿元（含采矿权）在上林县投资建设东方雨虹上林县新材料 产业链项目。其中，为满足生产基地项目的可持续发展，甲方为乙方项目配套饰面用灰岩矿权，2025年 9月24日，南宁东方雨虹参与上林县塘红乡石蓬村弄来庄敢内山饰面用灰岩矿采矿权的竞拍，并以人民 币26,700万元竞拍成功。 格隆汇9月25日丨东方雨虹(002271.SZ)公布，公司为立足公司建筑建材系统服务商的核心定位，借助防 水主业所积累的客户资源、销售渠道的协同性及良好的品牌影响力，实现以砂浆粉料为代表的非防水业 务较快发展；同时，依托上林县在矿产资源、区位条件及产业政策支持等方面的优势，在原有业务基础 上向砂浆粉料等产品的上游领域自然延伸，拟获取上游矿产资源，进行矿产资源综合开发及深加工，完 善产业链条的同时，加快公司向工业领域的布局，并对砂浆粉料等部分产品关键性原材料的供应稳定 性、降低原材料价格波动风险及成本优化形成良好的保障，提升公司采购环节的抗风险能力，确保供应 链安全、高效，进一步构筑及加深行业护城河，打造新的利 ...